Shilpa Medicare profit hits ₹108 cr as pharma operations turn around

Shilpa Medicare finished FY26 with a change in performance. Consolidated revenue rose 32% to ₹437 crore for the March quarter. Net profit reached ₹108 crore against ₹14.5 crore a year ago, aided by an ₹18.2 crore share of profit from a foreign associate and gains from a joint venture stake sale. The standalone results confirm the shift, moving from a ₹5.6 crore loss in Q4FY25 to a ₹71 crore profit. The company is using its cash position to pay a 60 paise dividend and put ₹4.44 crore into a 28% stake in Neo Green Power. Moving the registered office from Karnataka to Maharashtra marks a change for the board. The next test is whether the pharma business maintains this profit growth without non-operating income.